tirzepatide surmount 3 Delivers Long-Term Weight Loss — and the Numbers Prove It If you're struggling with weight and have prediabetes, a breakthrough treatment may offer lasting results. New data from the SURMOUNT-1 trial SURMOUNT 1 // Three-Year Obesty

Meal timing and composition Tirzepatide slows gastric emptying, meaning food stays in your stomach longer

A landmark trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with results improving at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, North Carolina residents across the state, from Asheville to Wilmington, have real, practical access to tirzepatide today

You have to be eligible for these medications, which means meeting certain health criteria set by the FDA

However, research has quickly revealed the Tirzepatide treatment drug has an additional advantage: it helps people shed weight